Trial intelligence / Profile preview

Ivabradine for Myocardial Injury After Non-cardiac Surgery

NCT04436016Phase 4Completed

Start
Oct 2020
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ivabradine in Myocardial injury. Started Oct 2020; status: completed.

02

Drugs

ivabradine
03

Conditions

Myocardial injury

Beyond the preview

Go deeper on NCT04436016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04436016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call